Metraipolis › archive › dc_501f9067cfa8

Immune checkpoint inhibitors in advanced cholangiocarcinoma: a systematic review of efficacy, safety, and emerging biomarkers — Europe PMC PMID:42406230

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42406230
DOI
10.1186/s43046-[numero omesso]-8
License (as archived)
solo-consultazione
Archived
2026-10-18T11:08:41.072Z
SHA-256 of the archived text
e0ea10d16cbcd3aa5e059675f267a03f36bd01abc9905e6ef001067531077955
Stable URL of this page
https://metraipolis.com/documento/dc_501f9067cfa8

How to cite

Immune checkpoint inhibitors in advanced cholangiocarcinoma: a systematic review of efficacy, safety, and emerging biomarkers — Europe PMC PMID:42406230 — Europe PMC (en), https://europepmc.org/article/MED/42406230 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_501f9067cfa8 (Metraipolis archive dc_501f9067cfa8, sha256 e0ea10d16cbcd3aa5e059675f267a03f36bd01abc9905e6ef001067531077955)
BibTeX
@misc{dc501f9067cfa8,
  title = {Immune checkpoint inhibitors in advanced cholangiocarcinoma: a systematic review of efficacy, safety, and emerging biomarkers — Europe PMC PMID:42406230},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42406230},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_501f9067cfa8; sha256 e0ea10d16cbcd3aa5e059675f267a03f36bd01abc9905e6ef001067531077955},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42406230. Agents can read the archived copy with the MCP tool read_document.